George joined M.M. Dillon & Co. in 2009, which was also previously known as CRT Investment Banking. Prior to that, he was a Managing Director at CRT Capital Group specializing in healthcare banking from 2005. Prior to joining CRT Capital Group George was Chief Financial Officer of Novartis Pharma AG located in Basel, Switzerland.
George has been instrumental in establishing the strategic, operating and financial direction of numerous private and public companies. During his career he has provided financial leadership for mergers and acquisitions valued at more than $50 billion and has funded and operated various venture capital businesses.
George has a broad range of operating and finance experiences. After receiving engineering and business degrees, he started his career at General Electric in manufacturing and then moved into finance. He subsequently joined The Dun & Bradstreet Corporation where he held various senior finance positions including Chief Financial Officer of IMS Health, the largest global publicly traded healthcare information services provider.
George has been on the board of directors and board of trustees of more than a dozen international private and public companies and philanthropic organizations. He has been a guest speaker on global finance at various international industry associations and graduate business schools, including Harvard Business School. George have lived and worked in five countries on four continents.